AtriCure - 14 Year Stock Price History | ATRC
Historical daily share price chart and data for AtriCure since 2005 adjusted for splits. The latest closing stock price for AtriCure as of June 24, 2019 is 30.21.
- The all-time high AtriCure stock price is 35.58, which is 17.8% above the current share price.
- The AtriCure 52-week high stock price is 35.58, which is 17.8% above the current share price.
- The AtriCure 52-week low stock price is 26.38, which is 12.7% below the current share price.
- The average AtriCure stock price for the last 52 weeks is 30.57.
| AtriCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 29.7758 | 30.2500 | 33.3400 | 26.3800 | 30.2100 | -1.27% |
| 2018 | 26.1470 | 18.4700 | 35.5800 | 15.0500 | 30.6000 | 67.76% |
| 2017 | 20.3076 | 19.2000 | 24.8800 | 14.9400 | 18.2400 | -6.80% |
| 2016 | 16.5649 | 21.1600 | 21.4700 | 13.5400 | 19.5700 | -12.79% |
| 2015 | 21.8535 | 19.7800 | 27.9300 | 17.4000 | 22.4400 | 12.42% |
| 2014 | 17.5247 | 18.0300 | 22.1800 | 13.6400 | 19.9600 | 6.85% |
| 2013 | 10.3316 | 7.1400 | 18.9300 | 7.1400 | 18.6800 | 170.72% |
| 2012 | 8.5684 | 11.7400 | 11.9600 | 5.9100 | 6.9000 | -37.84% |
| 2011 | 11.4511 | 10.2500 | 14.5000 | 8.5400 | 11.1000 | 8.08% |
| 2010 | 6.7755 | 5.6500 | 10.2700 | 4.5600 | 10.2700 | 70.03% |
| 2009 | 3.2447 | 2.2000 | 6.0500 | 1.0700 | 6.0400 | 172.07% |
| 2008 | 9.7793 | 13.2400 | 14.0500 | 2.0000 | 2.2200 | -83.07% |
| 2007 | 10.6159 | 9.1500 | 13.5900 | 8.4400 | 13.1100 | 46.64% |
| 2006 | 8.1361 | 10.7900 | 11.8000 | 5.4400 | 8.9400 | -16.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.159B | $0.202B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $149.955B | 29.11 |
| Medtronic (MDT) | Ireland | $133.284B | 19.04 |
| Stryker (SYK) | United States | $75.636B | 26.99 |
| Boston Scientific (BSX) | United States | $57.976B | 27.79 |
| Baxter (BAX) | United States | $42.043B | 26.50 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.226B | 15.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.156B | 0.00 |
| ResMed (RMD) | United States | $17.217B | 32.90 |
| Canopy Growth (CGC) | Canada | $13.835B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.076B | 48.12 |
| Aurora Cannabis (ACB) | Canada | $7.403B | 73.00 |
| Insulet (PODD) | United States | $7.147B | 520.74 |
| Hill-Rom Holdings (HRC) | United States | $6.992B | 21.20 |
| Perrigo (PRGO) | Ireland | $6.052B | 10.23 |
| Haemonetics (HAE) | United States | $6.021B | 49.14 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.237B | 0.00 |
| ICU Medical (ICUI) | United States | $5.130B | 30.61 |
| Hutchison China MediTech (HCM) | China | $3.814B | 0.00 |
| Neogen (NEOG) | United States | $3.238B | 52.65 |
| Agios Pharmaceuticals (AGIO) | United States | $2.981B | 0.00 |
| NuVasive (NUVA) | United States | $2.962B | 24.19 |
| National Vision Holdings (EYE) | United States | $2.499B | 53.25 |
| Quidel (QDEL) | United States | $2.360B | 24.49 |
| Aphria (APHA) | $1.687B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.495B | 858.80 |
| Phibro Animal Health (PAHC) | United States | $1.220B | 18.28 |
| VAREX IMAGING (VREX) | United States | $1.119B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $1.081B | 28.71 |
| OrganiGram Holdings (OGI) | Canada | $0.993B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.935B | 0.00 |
| PetIQ (PETQ) | United States | $0.899B | 21.84 |
| Quanterix (QTRX) | United States | $0.846B | 0.00 |
| MacroGenics (MGNX) | United States | $0.812B | 0.00 |
| Omeros (OMER) | United States | $0.794B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 21.61 |
| Cerus (CERS) | United States | $0.682B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.638B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 83.20 |
| OraSure Technologies (OSUR) | United States | $0.552B | 25.40 |
| LeMaitre Vascular (LMAT) | United States | $0.545B | 26.37 |
| Meridian Bioscience (VIVO) | United States | $0.489B | 14.95 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.355B | 0.00 |
| Zynex (ZYXI) | United States | $0.355B | 36.73 |
| BioLife Solutions (BLFS) | United States | $0.311B | 97.41 |
| Utah Medical Products (UTMD) | United States | $0.302B | 20.93 |
| Bovie Medical (APYX) | United States | $0.217B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.210B | 0.00 |
| Owens & Minor (OMI) | United States | $0.193B | 4.08 |
| Chimerix (CMRX) | United States | $0.173B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.140B | 7.38 |
| Female Health (VERU) | United States | $0.134B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.111B | 0.00 |
| Neurotrope (NTRP) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| Surface Oncology (SURF) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 19.21 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Senestech (SNES) | United States | $0.039B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.039B | 13.58 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.031B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.030B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.007B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 3.73 |
